Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Prostate drug tested as first real option for women who Can't empty their bladder

NCT ID NCT07822113

Symptom relief Sponsor: Jaber Al Ahmad Al Sabah Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 16, 2026 · Last updated Sep 17, 2026 · Updated 1 time

Summary

Many adult women struggle to start urinating, have a weak stream, or feel their bladder never fully empties. Doctors have few proven medicines for this problem. Researchers in Kuwait are running a randomized crossover trial of silodosin, a drug that relaxes the muscle at the bladder outlet and is already used in men. About 150 women will take silodosin and a placebo for 8 weeks each, with a washout between, so each woman serves as her own comparison. The trial measures changes in urinary symptom scores and side effects.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
silodosin, an oral drug that relaxes the muscle at the bladder outlet
What this could lead to
If it works, silodosin could become a drug option for women whose bladder does not empty well, a group with few proven medicines.
What could go wrong
This is a mid-stage trial of 150 women, so results may not hold in larger groups. Silodosin can cause dizziness, low blood pressure, or a runny nose, and it may not help every type of voiding problem.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Eligible participants must have clinically significant voiding symptoms including one or more of the following: * Difficulty initiating voiding * Slow urinary stream * Intermittent urinary stream * Straining to void * Sensation of incomplete bladder emptying AND at least one objective parameter suggestive of impaired bladder emptying: * Post-void residual urine volume ≥100 mL * Maximum urinary flow rate (Qmax) \<15 mL/sec with voided volume \>150 mL * Abnormal pressure-flow findings where available" Exclusion Criteria: * Pregnancy or breastfeeding * Active urinary tract infection * Neurogenic bladder dysfunction * Significant pelvic organ prolapse requiring intervention * Previous bladder outlet or urethral surgery * Severe renal or hepatic impairment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Female luts are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Female luts Voiding dysfunction

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Amiri Hospital

    Kuwait City, Kuwait, 00000, Kuwait

  • Farwaniya Hospital

    Kuwait City, Kuwait, 00000, Kuwait

  • Jaber Al Ahmad Al Jaber Al Sobah Hospital

    Kuwait City, Kuwait, 00000, Kuwait

More trials for these conditions

Other studies related to the condition(s) this trial covers.